« Return to News | Awards & Advancement | CROs/Service Providers

Clinilabs Names Greenberg Director of Expanded Unit

Wednesday, November 26, 2008 06:00 AM

New York, NY-based contract research organization (CRO) Clinilabs appointed Howard Greenberg, M.D., senior medical director of the company’s newly expanded clinical pharmacology unit. Greenberg has served as the principal investigator or co-investigator for more than 100 clinical trials and co-authored more than 30 peer-reviewed research publications. Most recently, he was group medical director at Bristol-Meyers Squibb.

Other personnel news from the clinical trials industry:

Imaging contract research organization WorldCare Clinical (WCC) has appointed John Tomera, Ph.D., to the newly created position of director of regulatory affairs and associate medical director. In this role, Tomera will manage quality assurance and regulatory affairs for the Boston-based company as well as provide medical expertise to WCC project teams. Prior to joining WCC, Tomera served as director of regulatory affairs at Biopure.

Bernard Mulder, M.D., has joined Avantium, as global vice president business development pharma to lead the technology company’s business development team for its pharmaceutical business. Mulder previously held several international positions at Organon.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.